| Is intraductal tubulopapillary neoplasia a new entity in the spectrum of familial pancreatic cancer syndrome? |
|
|
|
|
|
|
|
|
|
| Attitudes and knowledge of medical practitioners to hereditary cancer clinics and cancer genetic testing |
|
|
|
|
|
|
|
|
|
| Breast cancer risk assessment in 8,824 women attending a family history evaluation and screening programme |
|
|
|
|
|
|
|
|
|
| Evaluation after five years of the cancer genetic counselling programme of Valencian Community (Eastern Spain) |
|
|
|
|
|
|
|
|
|
| Ectopic Cushing syndrome associated with thymic carcinoid tumor as the first presentation of MEN1 syndrome-report of a family with MEN1 gene mutation |
|
|
|
|
|
|
|
|
|
| A randomized controlled trial of diet and physical activity in BRCA mutation carriers |
|
|
|
|
|
|
|
|
|
| RAD51 135G>C and TP53 Arg72Pro polymorphisms and susceptibility to breast cancer in Serbian women |
|
|
|
|
|
|
|
|
|
| Inversion of exons 1–7 of the MSH2 gene is a frequent cause of unexplained Lynch syndrome in one local population |
|
|
|
|
|
|
|
|
|
| Impact of familial risk and mammography screening on prognostic indicators of breast disease among women from the Ontario site of the Breast Cancer Family Registry |
|
|
|
|
|
|
|
|
|
| Misperceptions of ovarian cancer risk in women at increased risk for hereditary ovarian cancer |
|
|
|
|
|
|
|
|
|
| Birt–Hogg–Dubé syndrome |
|
|
|
|
|
|
|
|
|
| Comparison of attitudes regarding preimplantation genetic diagnosis among patients with hereditary cancer syndromes |
|
|
|
|
|
|
|
|
|
| Diversity of the clinical presentation of the MMR gene biallelic mutations |
|
|
|
|
|
|
|
|
|
| More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling |
|
|
|
|
|
|
|
|
|
| Abstracts |
|
|
|
|
|
|
|
|
|
| Prevalence of PALB2 mutation c.509_510delGA in unselected breast cancer patients from Central and Eastern Europe |
|
|
|
|
|
|
|
|
|
| Genetic variation at 8q24, family history of cancer, and upper gastrointestinal cancers in a Chinese population |
|
|
|
|
|
|
|
|
|
| Cancer risk and overall survival in mismatch repair proficient hereditary non-polyposis colorectal cancer, Lynch syndrome and sporadic colorectal cancer |
|
|
|
|
|
|
|
|
|
| Reflex testing for Lynch syndrome: If we build it, will they come? Lessons learned from the uptake of clinical genetics services by individuals with newly diagnosed colorectal cancer (CRC) |
|
|
|
|
|
|
|
|
|
| Impact of breast cancer family history on tumor detection and tumor size in women newly-diagnosed with invasive breast cancer |
|
|
|
|
|
|
|
|
|
| Illness perceptions, risk perception and worry in SDH mutation carriers |
|
|
|
|
|
|
|
|
|
| Lynch Syndrome in high risk Ashkenazi Jews in Israel |
|
|
|
|
|
|
✓ |
|
Ashkenazi Jews |
| Lack of association between let-7 binding site polymorphism rs712 and risk of nasopharyngeal carcinoma |
|
|
|
|
|
|
|
|
|
| Role of rapid sequence whole-body MRI screening in SDH-associated hereditary paraganglioma families |
|
|
|
|
|
|
|
|
|
| Does and should breast cancer genetic counselling include lifestyle advice? |
|
|
|
|
|
|
|
|
|
| Cancer risk and genotype–phenotype correlations in PTEN hamartoma tumor syndrome |
|
|
|
|
|
|
|
|
|
| Erratum to: Birt–Hogg–Dubé: beyond the clinical manifestations |
|
|
|
|
|
|
|
|
|
| InSiGHT, pedigree, familial aspects of cancer and the Human Variome Project in conjunction with the COSA familial cancer group |
|
|
|
|
|
|
|
|
|
| Chemoprevention in Lynch syndrome |
|
|
|
|
|
|
|
|
|
| The MDM2 285G–309G haplotype is associated with an earlier age of tumour onset in patients with Li-Fraumeni syndrome |
|
|
|
|
|
|
|
|
|
| Endometrial tumour BRAF mutations and MLH1 promoter methylation as predictors of germline mismatch repair gene mutation status: a literature review |
|
|
|
|
|
|
|
|
|
| No evidence of genetic anticipation in a large family with Lynch syndrome |
|
|
|
|
|
|
|
|
|
| Barrett’s esophagus in the patients with familial adenomatous polyposis |
|
|
|
|
|
|
|
|
|
| Towards a vaccine to prevent cancer in Lynch syndrome patients |
|
|
|
|
|
|
|
|
|
| Endometrial and ovarian cancer in women with Lynch syndrome: update in screening and prevention |
|
|
|
|
|
|
|
|
|
| Whole exome sequencing identifies mutation of EDNRA involved in ACTH-independent macronodular adrenal hyperplasia |
|
|
|
|
|
|
|
|
|
| The prevalence of small intestinal polyps in patients with familial adenomatous polyposis: a prospective capsule endoscopy study |
|
|
|
|
|
|
|
|
|
| MAX mutations status in Swedish patients with pheochromocytoma and paraganglioma tumours |
|
|
|
|
|
|
✓ |
|
Swedish patients |
| Mammographic surveillance in women aged 35–39 at enhanced familial risk of breast cancer (FH02) |
|
|
|
|
|
|
|
|
|
| Multivariate analysis of MLH1 c.1664T>C (p.Leu555Pro) mismatch repair gene variant demonstrates its pathogenicity |
|
|
|
|
|
|
|
|
|
| Pulmonary manifestations of Birt-Hogg-Dubé syndrome |
|
|
|
|
|
|
|
|
|
| Polymorphisms in arachidonic acid metabolism-related genes and the risk and prognosis of colorectal cancer |
|
|
|
|
|
|
|
|
|
| Surveillance for urinary tract cancer in Lynch syndrome |
|
|
|
|
|
|
|
|
|
| Screening participation for people at increased risk of colorectal cancer due to family history: a systematic review and meta-analysis |
|
|
|
|
|
|
|
|
|
| Diagnosis and management of BHD-associated kidney cancer |
|
|
|
|
|
|
|
|
|
| Value-based healthcare in Lynch syndrome |
|
|
|
|
|
|
|
|
|
| Rectal cancers in patients with familial adenomatous polyposis |
|
|
|
|
|
|
|
|
|
| 100 years lynch syndrome: what have we learned about psychosocial issues? |
|
|
|
|
|
|
|
|
|
| A hundred years of Lynch syndrome research (1913–2013) |
|
|
|
|
|
|
|
|
|
| Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry |
|
|
|
|
|
|
|
|
|
| “High rate of recurrent adenomatosis during endoscopic surveillance after duodenectomy in patients with familial adenomatous polyposis” |
|
|
|
|
|
|
|
|
|
| Foreword for “100 years of Lynch syndrome” |
|
|
|
|
|
|
|
|
|
| Do lifestyle factors influence colorectal cancer risk in Lynch syndrome? |
|
|
|
|
|
|
|
|
|
| Association of the BRCA1 promoter polymorphism rs11655505 with the risk of familial breast and/or ovarian cancer |
|
|
|
|
|
|
|
|
|
| Underestimated survival predictions of the prognostic tools Adjuvant! Online and PREDICT in BRCA1-associated breast cancer patients |
|
|
|
|
|
|
|
|
|
| The Proceedings of the Collaborative Group of the Americas on Inherited Colorectal Cancer Sheraton Boston Hotel, Boston, Massachusetts, October 27–29, 2012 |
|
|
|
|
|
|
|
|
|
| Case report: metachronous central nervous system desmoid tumours and thyroid carcinoma in a young familial adenomatous polyposis patient |
|
|
|
|
|
|
|
|
|
| Cancer risk in Lynch Syndrome |
|
|
|
|
|
|
|
|
|
| Can we test for hereditary cancer at 18 years when we start surveillance at 25? Patient reported outcomes |
|
|
|
|
|
|
|
|
|
| Extracolonic cancer risk in patients with serrated polyposis syndrome and their first-degree relatives |
|
|
|
|
|
|
|
|
|
| The mechanism of mismatch repair and the functional analysis of mismatch repair defects in Lynch syndrome |
|
|
|
|
|
|
|
|
|
| How do we approach the goal of identifying everybody with Lynch Syndrome? |
|
|
|
|
|
|
|
|
|
| Self administered screening for hereditary cancers in conjunction with mammography and ultrasound |
|
|
|
|
|
|
|
|
|
| Do individuals with a family history of colorectal cancer adhere to medical recommendations for the prevention of colorectal cancer? |
|
|
|
|
|
|
|
|
|
| The History of Lynch Syndrome |
|
|
|
|
|
|
|
|
|
| Prediction models in Lynch syndrome |
|
|
|
|
|
|
|
|
|
| Chemotherapy of MMR-deficient colorectal cancer |
|
|
|
|
|
|
|
|
|
| Informing family members of individuals with Lynch syndrome: a guideline for clinical geneticists |
|
|
|
|
|
|
|
|
|
| Lynch syndrome: the patients perspective |
|
|
|
|
|
|
|
|
|
| Gene variants of unknown clinical significance in Lynch syndrome. An introduction for clinicians |
|
|
|
|
|
|
|
|
|
| Colorectal surveillance in Lynch syndrome families |
|
|
|
|
|
|
|
|
|
| Psychosocial consequences of predictive genetic testing for lynch syndrome and associations to surveillance behaviour in a 7-year follow-up study |
|
|
|
|
|
|
|
|
|
| Surgical treatment of hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) |
|
|
|
|
|
|
|
|
|
| Interest of individuals from BRCA families to participate in research studies focused on male BRCA carriers |
|
|
|
|
|
|
|
|
|
| Factors affecting the decision to undergo risk-reducing salpingo-oophorectomy among women with BRCA gene mutation |
|
|
|
|
|
|
|
|
|
| Frameshift mutation in the PTCH2 gene can cause nevoid basal cell carcinoma syndrome |
|
|
|
|
|
|
|
|
|
| Novel and recurrent BRCA1/BRCA2 mutations in early onset and familial breast and ovarian cancer detected in the Program of Genetic Counseling in Cancer of Valencian Community (eastern Spain). Relation |
|
|
|
|
|
|
|
|
|
| Is the psychological impact of genetic testing moderated by support and sharing of test results to family and friends? |
|
|
|
|
|
|
|
|
|
| Prevalence of HOXB13 mutation in a population of Ashkenazi Jewish men treated for prostate cancer |
|
|
|
|
|
|
✓ |
|
Ashkenazi Jewish |
| Genetic modifiers of cancer risk in Lynch syndrome: a review |
|
|
|
|
|
|
|
|
|
| The incidence of PALB2 c.3113G>A in women with a strong family history of breast and ovarian cancer attending familial cancer centres in Australia |
|
|
|
|
|
|
|
|
|
| Clinical characterization and mutation spectrum in Hispanic families with adenomatous polyposis syndromes |
|
|
|
|
|
|
|
|
|
| The role of epigenetics in Lynch syndrome |
|
|
|
|
|
|
|
|
|
| The InSiGHT database: utilizing 100 years of insights into Lynch Syndrome |
|
|
|
|
|
|
|
|
|
| Lynch syndrome-associated neoplasms: a discussion on histopathology and immunohistochemistry |
|
|
|
|
|
|
|
|
|
| Role of new endoscopic techniques in Lynch syndrome |
|
|
|
|
|
|
|
|
|
| Preparing individuals to communicate genetic test results to their relatives: report of a randomized control trial |
|
|
|
|
|
|
|
|
|
| Mutation screen and RNA analysis disclose the changed splicing of the E-cadherin transcription in gastric cancer |
|
|
|
|
|
|
|
|
|
| 13th International Meeting on Psychosocial Aspects of Hereditary Cancer (IMPAHC) |
|
|
|
|
|
|
|
|
|
| Familial adenomatous polyposis: not all masses are desmoids |
|
|
|
|
|
|
|
|
|
| Detection of large deletions in the VHL gene using a Real-Time PCR with SYBR Green |
|
|
|
|
|
|
|
|
|
| The prognostic value of MGMT promoter methylation in Glioblastoma multiforme: a meta-analysis |
|
|
|
|
|
|
|
|
|
| Mutation screening in a Norwegian cohort with pheochromocytoma |
|
|
|
|
|
|
|
|
|
| Erratum to: Closing the loop: an interactive action research conference format for delivering updated medical information while eliciting Latina patient/family experiences and psychosocial needs post- |
|
|
|
|
|
|
|
|
|
| Erratum to: Evaluating Lynch syndrome in very early onset colorectal cancer probands without apparent polyposis |
|
|
|
|
|
|
|
|
|
| GNAS is not involved in gastrointestinal tumour formation in Peutz-Jeghers syndrome |
|
|
|
|
|
|
|
|
|
| Splice site mutations in mismatch repair genes and risk of cancer in the general population |
|
|
|
|
|
|
|
|
|
| Erratum to: Birt–Hogg–Dubé syndrome: from gene discovery to molecularly targeted therapies |
|
|
|
|
|
|
|
|
|
| The risk of gastric cancer in carriers of CHEK2 mutations |
|
|
|
|
|
|
|
|
|
| Birt–Hogg–Dubé syndrome and the skin |
|
|
|
|
|
|
|
|
|
| Detection of large scale 3′ deletions in the PMS2 gene amongst Colon-CFR participants: have we been missing anything? |
|
|
|
|
|
|
|
|
|